PBPs are more than static β lactam targets. Host conditions rewire PBP activity and peptidoglycan architecture, shaping tolerance, resistance, and how we design salvage regimens.
Ben Albrecht, PharmD, BCIDP
Advertisement
Albrecht is a clinical pharmacy specialist in Infectious Diseases at Emory University Hospital and Emory University Orthopedics and Spine Hospital as well as an adjunct assistant professor for the Emory University School of Medicine, Department of Infectious Disease. His practice includes direct patient care with the general and transplant infectious disease consult services as well as antimicrobial stewardship. His research interests include emerging infectious pathogens, antimicrobial resistance, and pharmacokinetics.
(ORCID: 0000-0003-2834-3972)
Articles by Ben Albrecht, PharmD, BCIDP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Dynavax and Vaxart Partner to Advance Oral COVID-19 Vaccine
2
Penicillin-Binding Proteins Reconsidered: A Clinician's Guide from Targets to Dynamic Cell-Wall Control
3
Using Doxycycline for Post-Exposure Prevention of Lyme Disease in Young Kids
4
